[1] |
WANG Yan, ZHANG Jinhui, ZHAO Yongchen, LIU Hongxiang, LIU Yawei, MIAO Huanhuan, YANG Xincai.
Sequoiaflavone inhibits stem cell properties such as proliferation and invasion of gastric cancer cells by down-regulating PI3K/AKT signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 508-513.
|
[2] |
WANG Dan, YAN Xiaoli, ZHANG Yuan.
Helicobacter pylori infection influences the efficacy of immunotherapies for gastric cancer#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 228-234.
|
[3] |
LIU Le, QI Wenbo, BAI Yuping, LIU Qian, YIN Zhenyu, LI Xiaomei, YU Yang, CHEN Hao.
Influencing factors of PD-1/PD-L1 immune checkpoint inhibitor immunotherapy for gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 95-101.
|
[4] |
JIANG Yuhua, ZHI Hui, LU Linming, TIAN Dahao, WANG Xiaoqing, GE Yu, XIE Shangfu, WANG Qi.
AHVAC-I reverses tumor growth of cancer-associated fibroblasats in gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 389-394.
|
[5] |
Pazilaiti YASEN, YUAN Hao, LU Hong, ZHENG Ya, WANG Yuping, ZHOU Yongning.
Research progress in clinical trials of targeted drugs for gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 454-461.
|
[6] |
WU Yi, ZHU Akao, SHAN Yuqiang, YING Rongchao, JIN Huicheng.
Resveratrol regulates miR-409-3p/FKBP14 to inhibit the malignant biological processes of gastric cancer BGC823 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 968-975.
|
[7] |
TIAN Dahao, LU Linming, ZHI Hui, ZHOU Jue, WANG Xiaoqing, JIANG Yuhua.
AHVAC-I inhibits the proliferation in human primary gastric cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 505-511.
|
[8] |
SHEN Cheng, YANG Nianzhao, WANG Minghai, WU Lisheng, ZHU Zhiqiang.
Inhibiting RNA methylase NSUN2 reduce the invasion and migration of gastric cancer cell
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 380-386.
|
[9] |
LIU Yujia, LI Li, HU Xiaoping, ZHONG Like, LI Jingjing, HUANG Ping, ZHANG Yiwen.
A correlation analysis between survival rate and the characteristic gene of gastric cancer based on bioinformatics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 852-859.
|
[10] |
TENG Xiaojing, DONG Xueyan, WANG Zhiyi, YU Daojun, WANG Xianjun.
Experimental study of Fuzheng Kangfu mixture combined with cisplatin on apoptosis of the gastric cancer cell SGC7901
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(7): 744-749.
|
[11] |
DONG Jinliang.
Effects of weekly liposome paclitaxel combined with tiggio on serum tumor markers and soluble e-cadherin in elderly patients with advanced gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(7): 805-809.
|
[12] |
DAI Lei, LUO Linghe, WU Liyan, WANG Gang, FEI Baoying.
Expression of miR-222 and MBD2 in gastric cancer patients and their effects on platinum chemosensitivity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 623-629.
|
[13] |
ZHANG Tengyue, YANG Guangshan, MA Kelong, FAN Pingsheng.
Clinical study of anticoagulant therapy on hypercoagulable state and anti-tumor metastasis in advanced gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 433-439.
|
[14] |
LI Yuqin, WANG Kai, AO Li, LU Xiaolan, SHI Jianping.
miR-142-5p inhibits proliferation and migration of gastric cancer cells through DNMT1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1328-1334.
|
[15] |
LIAN Yanhong, JIANG Huifang, YUAN Xiaohong, ZHOU Huidan, XIE Kangjie, FANG Jun, JIN Xiaoju.
Effects of neoadjuvant chemotherapy on the pharmacodynamics of rocuronium bromide in patients undergoing gastric cancer surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(10): 1161-1164.
|